HAW PAR CORPORATION LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.82 SGD | -0.71% |
|
+1.03% | +0.72% |
| Sales 2022 | 182M 134M 11.14B | Sales 2023 | 232M 170M 14.2B | Capitalization | 2.16B 1.58B 132B |
|---|---|---|---|---|---|
| Net income 2022 | 148M 109M 9.06B | Net income 2023 | 217M 159M 13.28B | EV / Sales 2022 | 9.97 x |
| Net cash position 2022 | 305M 224M 18.67B | Net cash position 2023 | 546M 400M 33.38B | EV / Sales 2023 | 6.95 x |
| P/E ratio 2022 |
14.3
x | P/E ratio 2023 |
9.97
x | Employees | 595 |
| Yield 2022 |
3.13% | Yield 2023 |
4.1% | Free-Float | 61.41% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.71% | ||
| 1 week | +1.03% | ||
| Current month | +1.45% | ||
| 1 month | +1.24% | ||
| 3 months | +2.83% | ||
| 6 months | +2.51% | ||
| Current year | +0.72% |
1 week
9.72
9.92
1 month
9.609.92
Current year
9.4410.10
1 year
9.1110.22
3 years
8.9813.80
5 years
8.9814.86
10 years
7.2014.86
| Managers | Title | Age | Since |
|---|---|---|---|
Ee Lim Wee
CEO | Chief Executive Officer | 63 | 23/94/23 |
Say Suan Chow
DFI | Director of Finance/CFO | 51 | 01/00/01 |
Lily Lee Lee Su
AUD | Comptroller/Controller/Auditor | - | 01/12/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ee Lim Wee
CEO | Chief Executive Officer | 63 | 23/94/23 |
Ee Chao Wee
CHM | Chairman | 71 | 08/03/08 |
Sim Ho Ong
BRD | Director/Board Member | 55 | 10/21/10 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 9.82 | -0.71% | 50,600 |
| 25/24/25 | 9.89 | -0.10% | 11,100 |
| 24/24/24 | 9.9 | +0.30% | 38,900 |
| 23/24/23 | 9.87 | +0.20% | 71,900 |
| 22/24/22 | 9.85 | +1.34% | 41,300 |
Delayed Quote Singapore S.E., April 26, 2024 at 02:34 pm IST
More quotes
Haw Par Corporation Limited is a Singapore-based holding company. The principal activities of the Company are licensing of the Tiger trademarks and owning and holding investments for the long-term. Its segments include Healthcare products, Investments and Others. The Company's Healthcare products segment is engaged in manufacturing and distributing topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment is engaged in long term investing activities, mainly in quoted securities in Asia. The Company's Others segment includes property division, which owns and leases out several investment properties in Asia, and leisure division, which provides family and tourist-oriented leisure activities in the form of oceanariums. Its Tiger Balm brand products include Tiger Balm White Ointment, Tiger Balm Muscle Rub, Tiger Balm Back Pain Patch and Tiger Balm Muscle Rub. Its Kwan Loong brand products include Kwan Loong Medicated and Oil Kwan Loong Refresher.
Sector
Pharmaceuticals
Calendar
03/05/2024
- Final dividend
| 1st Jan change | Capi. | |
|---|---|---|
| +0.72% | 1.6B | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- H02 Stock
